Skip to content

BRAFO: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

BRAFO

BE 0598.967.377
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€367,269
2024 · €261,505+€105,764
Equity
€1.8m
2024 · €1.5m+€365,603
Cash
€26,111
2024 · €113,948-€87,837
Balance sheet total
€3.5m
2024 · €3.4m+€61,401

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€166,516

    up €166,516 (+17.6%), from €948,448 to €1.1m

    of which Other amounts receivable: +€174,929

  • Cash -€87,837

    down €87,837 (-77.1%), from €113,948 to €26,111

    mainly Current portion of long-term debt (-€200,000) and Receivables within one year (-€166,516)

Equity and liabilities
  • Reserves +€365,603

    up €365,603 (+25.4%), from €1.4m to €1.8m

  • Current portion of long-term debt -€200,000

    down €200,000 (-55.8%), from €358,267 to €158,267

  • Debts after one year -€158,267

    down €158,267 (-13.9%), from €1.1m to €979,733

  • Tax, wage and social debts +€42,037

    up €42,037 (+132.7%), from €31,682 to €73,718

    of which Taxes: +€42,037

Income statement
  • Gross operating margin +€157,553

    up €157,553 (+35.5%), from €444,366 to €601,919

  • Taxes +€50,941

    up €50,941 (+43.5%), from €117,047 to €167,988

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €261,505
Gross operating margin +€157,553
Depreciation -€326
Other operating charges -€88
Other operating items +€106
Financial income -€2,492
Financial charges +€1,953
Taxes -€50,941
Result 2025 €367,269

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€272,096
Investment €0
Financing -€359,933
Cash 2024 €113,948
Net result for the year +€367,269
Depreciation +€16,413
Receivables within one year -€166,516
Smaller working-capital items +€810
Trade debts +€10,522
Tax, wage and social debts +€42,037
Accrued charges and deferred income +€1,561
Debts after one year -€158,267
Current portion of long-term debt -€200,000
Contributions, distributions and other -€1,666
Cash 2025 €26,111
Every line side by side 43 lines
Line Code 2024 2025 Change %
Total assets 20/58 €3,428,846 €3,490,247 +€61,401 +1.8%
Fixed assets 21/28 €2,353,103 €2,336,690 -€16,413 -0.7%
Tangible fixed assets 22/27 €329,453 €313,040 -€16,413 -5.0%
Land and buildings 22 €304,526 €296,785 -€7,741 -2.5%
Furniture and vehicles 24 €24,927 €16,255 -€8,672 -34.8%
Financial fixed assets 28 €2,023,650 €2,023,650 = 0.0%
Current assets 29/58 €1,075,742 €1,153,556 +€77,814 +7.2%
Amounts receivable within one year 40/41 €948,448 €1,114,963 +€166,516 +17.6%
Trade receivables 40 €187,420 €179,007 -€8,413 -4.5%
Other amounts receivable 41 €761,028 €935,957 +€174,929 +23.0%
Cash at bank and in hand 54/58 €113,948 €26,111 -€87,837 -77.1%
Deferred charges and accrued income 490/1 €13,346 €12,482 -€865 -6.5%
Total equity and liabilities 10/49 €3,428,846 €3,490,247 +€61,401 +1.8%
Equity 10/15 €1,459,924 €1,825,527 +€365,603 +25.0%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €1,441,324 €1,806,927 +€365,603 +25.4%
Distributable reserves 133 €1,441,324 €1,806,927 +€365,603 +25.4%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €1,968,921 €1,664,719 -€304,202 -15.5%
Amounts payable after more than one year 17 €1,137,999 €979,733 -€158,267 -13.9%
Financial debts 170/4 €1,137,999 €979,733 -€158,267 -13.9%
Amounts payable within one year 42/48 €795,198 €647,702 -€147,496 -18.5%
Current portion of amounts payable after more than one year 42 €358,267 €158,267 -€200,000 -55.8%
Trade debts 44 €10,246 €20,768 +€10,522 +102.7%
Suppliers 440/4 €10,246 €20,768 +€10,522 +102.7%
Taxes, remuneration and social security 45 €31,682 €73,718 +€42,037 +132.7%
Taxes 450/3 €29,078 €71,115 +€42,037 +144.6%
Remuneration and social security 454/9 €2,603 €2,603 = 0.0%
Other amounts payable 47/48 €395,004 €394,949 -€55 0.0%
Accrued charges and deferred income 492/3 €35,724 €37,285 +€1,561 +4.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €16,087 €16,413 +€326 +2.0%
Other operating charges 640/8 €2,762 €2,850 +€88 +3.2%
Non-recurring operating charges 66A €442 €336 -€106 -24.0%
Gross operating margin 9900 €444,366 €601,919 +€157,553 +35.5%
Operating profit (loss) 9901 €425,075 €582,321 +€157,245 +37.0%
Financial income 75/76B €29,640 €27,148 -€2,492 -8.4%
Recurring financial income 75 €29,640 €27,148 -€2,492 -8.4%
Financial charges 65/66B €76,164 €74,211 -€1,953 -2.6%
Recurring financial charges 65 €76,164 €74,211 -€1,953 -2.6%
Profit (loss) for the period before taxes 9903 €378,552 €535,257 +€156,705 +41.4%
Income taxes 67/77 €117,047 €167,988 +€50,941 +43.5%
Profit (loss) for the period 9904 €261,505 €367,269 +€105,764 +40.4%
Profit (loss) for the period to be appropriated 9905 €261,505 €367,269 +€105,764 +40.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.